Want to join the conversation?
Biotechnology company $REGN said German drug giant Bayer HealthCare received European approval for eylea Injection, for the treatment of Myopic CNV, an eye disease associated with high degrees of myopia. $REGN is Bayer's U.S. development partner.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.